Subscribe To
Investigation of ImmunityBio, Inc. (IBRX) Announced by Holzer & Holzer, LLC
ATLANTA, May 18, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether ImmunityBio, Inc. (“ImmunityBio,” or the “Company”) (NASDAQ: IBRX) complied with federal securities laws. On May 11, 2023, ImmunityBio disclosed that it received a complete response letter from the FDA on May 9, 2023. The letter indicates that the FDA has determined that […] The post Investigation of ImmunityBio, Inc. (IBRX) Announced by Holzer & Holzer, LLC appeared first on ForexTV...
Read More
Posted: May 18 2023, 21:53
Author Name: forextv
Views: 081594